Lanzer, Michael
Michael Lanzer infectious disease physician
VIAF ID: 313447765 ( Personal )
Permalink: http://viaf.org/viaf/313447765
Preferred Forms
- 100 1 _ ‡a Lanzer, Michael
- 100 1 _ ‡a Lanzer, Michael
-
- 100 0 _ ‡a Michael Lanzer ‡c infectious disease physician
4xx's: Alternate Name Forms (3)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Characterization of amicarbalide derivatives as new antimalarial compounds: Investigation of the mode of action and the mechanism of resistance | |
Electron microscopic imaging and reconstruction of the spiral scaffold underlying knobs in Plasmodium falciparum-infected erythrocytes | |
Functional studies on the chloroquine resistance transporter (PfCRT) and the HECT E3 ubiquitin-protein ligase (PfUT) in Plasmodium falciparum | |
Genetic and molecular studies of the hexose transporter of Plasmodium species | |
Host and parasite factors of Plasmodium falciparum asymptomatic persistence during the dry season | |
In depth functional characterization of Plasmodium berghei ferlin-like protein | |
Investigating KAHRP export kinetics by super-resolution time-lapse microscopy in Plasmodium falciparum blood stages | |
Investigating the importance of exported proteins for survival and host cell modification in asexual blood stages of Plasmodium falciparum | |
Manipulation von Wirtszellmechanismen während der Infektion durch Gram-positive und Gram-negative Erreger in einem humanen Modell der Blut-Liquor-Schranke | |
Metabolic engineering of Synechococcus sp. strain PCC 7002 for the photoautotrophic production of riboflavin (vitamin B2) | |
Novel sub-unit and whole-organism vaccination appoaches against severe malaria in Plasmodium berghei | |
Old but gold: The Plasmodium falciparum merozoite surface protein 1 is still a promising blood stage vaccine candidate | |
P. falciparum dry season reservoir metabolism and in vitro drug susceptibility | |
P. vivax merozoite surface protein 1 (MSP-1): Development of a recombinant protein production process and structural characterisation of MSP-1 | |
Pathogen mimicry of eurkaryotic linear motifs | |
Plasmodium falciparum Antioxidant Protein: Kinetic Characterization and Physiological Relevance as a Potential Redox Sensor in Malaria Parasites | |
Protection against severe malaria by hemoglobin S and C: A quantitative understanding of the cytoadhesion behavior of Plasmodium falciparum infected erythrocytes | |
Redox-active 3-benzyl-menadiones as new antimalarial agents : studies on structure-activity relationships, antiparasitic potency and mechanism of action | |
RNAi-Competent Malaria Parasite: A Novel Strategy to Knock Down Plasmodium Genes via Non-Canonical RNAi | |
RNAi-kompetente Malaria-Parasit: Eine neue Strategie, Plasmodiumgene mittels nicht-kanonischer RNA-Interferenz herunterzuregulieren. | |
role of nuclear actin polymerization in CD4 T cell effector function | |
role of phase separation in centrin interactions during Plasmodium falciparum schizogony | |
Signal transduction during CNS invasion by Listeria monocytogenes and the role of CD44 in the invasion | |
Structure-function analysis and membrane association of Leishmania tarentolae and Plasmodium falciparum Erv | |
A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo | |
Target identification studies for SC83288: a novel drug for the treatment of severe malaria | |
Towards an in-depth analysis of proteomes : characterization of protein n-termini. | |
Transkriptomvergleich primärer und immortalisierter Endothelzellen des humanen Plexus choroideus unter Betrachtung des Wnt/b-catenin Signalweges | |
Vers une étude approfondie des protéomes : caractérisation des extrémités N-terminales des protéines |